Bolt Biotherapeutics, Inc. (BOLT)
USD 0.33
(-9.65%)
USD 0.33
(-9.65%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -53.66 Million USD | 615.04% |
| 2022 | 838 Thousand USD | 134.74% |
| 2021 | -2.41 Million USD | 93.99% |
| 2020 | -40.12 Million USD | -55.61% |
| 2019 | -25.78 Million USD | -8438.74% |
| 2018 | -302 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 818 Thousand USD | -393.98% |
| 2024 Q1 | 4.81 Million USD | 202.51% |
| 2023 Q2 | 244 Thousand USD | -61.88% |
| 2023 Q1 | 640 Thousand USD | 162.3% |
| 2023 FY | 5.99 Million USD | 615.04% |
| 2023 Q4 | 1.59 Million USD | -22.94% |
| 2023 Q3 | 2.06 Million USD | 746.72% |
| 2022 Q3 | -16.86 Million USD | 3.8% |
| 2022 Q2 | -17.52 Million USD | -2351.33% |
| 2022 FY | 838 Thousand USD | 134.74% |
| 2022 Q1 | -715 Thousand USD | -80.1% |
| 2022 Q4 | 244 Thousand USD | 101.45% |
| 2021 Q4 | -397 Thousand USD | 97.86% |
| 2021 Q2 | -900 Thousand USD | -12.22% |
| 2021 Q1 | -802 Thousand USD | 94.6% |
| 2021 Q3 | -18.58 Million USD | -1965.0% |
| 2021 FY | -2.41 Million USD | 93.99% |
| 2020 FY | -40.12 Million USD | -55.61% |
| 2020 Q4 | -14.86 Million USD | -55.81% |
| 2020 Q3 | -9.54 Million USD | -4.85% |
| 2020 Q2 | -9.09 Million USD | -37.38% |
| 2020 Q1 | -6.62 Million USD | 10.14% |
| 2019 Q1 | -6.15 Million USD | 0.0% |
| 2019 FY | -25.78 Million USD | -8438.74% |
| 2019 Q4 | -7.37 Million USD | -20.48% |
| 2019 Q3 | -6.11 Million USD | 0.54% |
| 2019 Q2 | -6.15 Million USD | 0.0% |
| 2018 FY | -302 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | 241.133% |
| Alkermes plc | 1.37 Billion USD | 103.904% |
| Agenus Inc. | 139.61 Million USD | 138.439% |
| Aptorum Group Limited | -1.11 Million USD | -4714.441% |
| Ardelyx, Inc. | 106.66 Million USD | 150.315% |
| Dyadic International, Inc. | 922.95 Thousand USD | 5914.572% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | 354.812% |
| Lantern Pharma Inc. | -174.84 Thousand USD | -30593.822% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | -301.756% |
| Novavax, Inc. | 639.93 Million USD | 108.386% |
| Janux Therapeutics, Inc. | -46.83 Million USD | -14.575% |
| Pyxis Oncology, Inc. | -2 Million USD | -2583.3% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | -10285.373% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | 381.815% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | -121349.262% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | -10083.302% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | Infinity% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 45.36% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | 6791.521% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -65346.341% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 139.674% |
| Clearside Biomedical, Inc. | 7.87 Million USD | 781.819% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 44.646% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 103.536% |
| AlloVir, Inc. | -398 Thousand USD | -13383.92% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 122.293% |
| VYNE Therapeutics Inc. | 424 Thousand USD | 12757.075% |
| Bicycle Therapeutics plc | -129.52 Million USD | 58.565% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | 44821.667% |
| ChromaDex Corporation | 50.78 Million USD | 205.683% |
| Chimerix, Inc. | 324 Thousand USD | 16663.58% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | -72.185% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 30.841% |
| CRISPR Therapeutics AG | 240.95 Million USD | 122.272% |
| Precision BioSciences, Inc. | 40.47 Million USD | 232.6% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 45.33% |
| Fortress Biotech, Inc. | 57.85 Million USD | 192.763% |
| Fortress Biotech, Inc. | 57.85 Million USD | 192.763% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | 423.738% |
| ImmuCell Corporation | 4.39 Million USD | 1320.713% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 49.43% |
| Immix Biopharma, Inc. | -5468.00 USD | -981355.743% |
| Incyte Corporation | 3.44 Billion USD | 101.56% |
| Innoviva, Inc. | 261.06 Million USD | 120.557% |
| IO Biotech, Inc. | -756 Thousand USD | -6998.677% |
| Jaguar Health, Inc. | 7.72 Million USD | 794.795% |
| Keros Therapeutics, Inc. | -664 Thousand USD | -7982.229% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 144.814% |
| ContextLogic Inc. | 59 Million USD | 190.959% |
| MiMedx Group, Inc. | 266.84 Million USD | 120.111% |
| MEI Pharma, Inc. | 49.32 Million USD | 208.796% |
| NextCure, Inc. | -3.68 Million USD | -1356.732% |
| Onconetix, Inc. | -1.12 Million USD | -4661.149% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | -85.26% |
| Opthea Limited | 21.72 Thousand USD | 247181.031% |
| Psyence Biomedical Ltd. | -240.00 USD | -22360733.333% |
| Vaxcyte, Inc. | -75 Million USD | 28.445% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | -93515.462% |
| Precigen, Inc. | 106 Thousand USD | 50728.302% |
| Pharming Group N.V. | 220.1 Million USD | 124.382% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | 10520.583% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | 5418.731% |
| PureTech Health plc | -1.6 Million USD | -3247.848% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 148.889% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 70.417% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | -18.403% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | -144.081% |
| Acelyrin, Inc. | -115 Thousand USD | -46566.087% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | -533836.922% |
| Summit Therapeutics Inc. | -2.05 Million USD | -2517.854% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | -9298.599% |
| Senti Biosciences, Inc. | -2.68 Million USD | -1900.224% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | 1424.759% |
| Elevation Oncology, Inc. | -39 Thousand USD | -137505.128% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | -1018.508% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -1261.374% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | 284.236% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | 10919.758% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | -97474.545% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 151.553% |
| Seer, Inc. | 7.02 Million USD | 863.711% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | 1325.811% |
| Aadi Bioscience, Inc. | 21.54 Million USD | 349.088% |
| ESSA Pharma Inc. | -118.49 Thousand USD | -45191.204% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | -37349.843% |
| GT Biopharma, Inc. | - USD | Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | 8912.151% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 144.546% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 117.109% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | -1073220.0% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | 2184.926% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | -105666.654% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | 282.618% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | -23031.897% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | -10807.724% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | -656.072% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | -11208.938% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | -515919.231% |
| Soligenix, Inc. | 97.31 Thousand USD | 55248.955% |
| Century Therapeutics, Inc. | -10.8 Million USD | -396.494% |
| Kura Oncology, Inc. | -849 Thousand USD | -6221.084% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 20.026% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | -36407.483% |
| Ocean Biomedical, Inc. | - USD | Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 154.187% |
| Autolus Therapeutics plc | -4.86 Million USD | -1002.651% |
| Mineralys Therapeutics, Inc. | - USD | Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | 229.672% |
| Eterna Therapeutics Inc. | -168 Thousand USD | -31844.048% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 156.656% |
| GRI Bio, Inc. | 10.84 Million USD | 595.028% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | 2212.846% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | -517.774% |
| IGM Biosciences, Inc. | -211.66 Million USD | 74.645% |
| INmune Bio, Inc. | 155 Thousand USD | 34723.226% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 186.643% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -3462.791% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -8175.992% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | -183223.085% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | 13449.751% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | -2588.677% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | -17045.687% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 156.813% |
| Verastem, Inc. | -62 Thousand USD | -86458.065% |
| Abeona Therapeutics Inc. | 2.43 Million USD | 2303.943% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | -20461.686% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | 1872.91% |
| Histogen Inc. | 3.76 Million USD | 1523.879% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | 9414.119% |
| Surrozen, Inc. | -27.23 Million USD | -97.084% |
| Organovo Holdings, Inc. | -5.38 Million USD | -895.843% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | -4354.054% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | -109.249% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | 367.634% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | -2710304.04% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | 984.64% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | -79842.203% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 134.67% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | 36907.956% |
| Apollomics, Inc. | 127 Thousand USD | 42356.693% |
| Amarin Corporation plc | 165.54 Million USD | 132.419% |
| Mesoblast Limited | -9.81 Million USD | -446.775% |
| Turnstone Biologics Corp. | 16.5 Million USD | 425.13% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 51.429% |
| Synaptogenix, Inc. | -6347.00 USD | -845433.323% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | -105127.451% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 133.258% |
| BriaCell Therapeutics Corp. | - USD | Infinity% |
| Monopar Therapeutics Inc. | - USD | Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 103.053% |
| Better Therapeutics, Inc. | -2.72 Million USD | -1866.508% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 52.153% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 115.874% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -470324.264% |
| Dermata Therapeutics, Inc. | - USD | Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | -757.284% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -4743.502% |
| TNF Pharmaceuticals, Inc. | - USD | Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | 833.342% |
| Insmed Incorporated | 239.63 Million USD | 122.395% |
| Virpax Pharmaceuticals, Inc. | - USD | Infinity% |
| MediWound Ltd. | 3.57 Million USD | 1599.888% |
| OmniAb, Inc. | 14.66 Million USD | 465.896% |
| Alector, Inc. | -95.05 Million USD | 43.541% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 142.721% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | -23.475% |
| Zai Lab Limited | 170.9 Million USD | 131.401% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 165.545% |
| Aura Biosciences, Inc. | -1.29 Million USD | -4044.093% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | 41381.538% |
| Immunic, Inc. | -111 Thousand USD | -48247.748% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | 438.501% |
| Veracyte, Inc. | 248.14 Million USD | 121.627% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 99.232% |
| FibroGen, Inc. | 128.9 Million USD | 141.633% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | -9515148.227% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | -359.986% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 101.579% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | 13895.887% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 115.103% |
| TG Therapeutics, Inc. | 219.1 Million USD | 124.493% |
| Galecto, Inc. | -830 Thousand USD | -6365.783% |
| Calithera Biosciences, Inc. | -1.38 Million USD | -3774.801% |
| Fortrea Holdings Inc. | 424 Million USD | 112.657% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 37.719% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | -9364.903% |
| XBiotech Inc. | -1.74 Million USD | -2977.179% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -4743.502% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | -15.483% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 28.951% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 173.111% |
| Theravance Biopharma, Inc. | 16.8 Million USD | 419.383% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 113.794% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | -8.095% |
| Vaxxinity, Inc. | -2.23 Million USD | -2302.238% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 116.424% |
| Gain Therapeutics, Inc. | -11.32 Million USD | -373.92% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | 319.484% |
| NexImmune, Inc. | -1.02 Million USD | -5135.85% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | 993914.815% |
| Marker Therapeutics, Inc. | -7.1 Million USD | -655.258% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 100.475% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | -80205.864% |
| Scopus BioPharma Inc. | - USD | Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | -1411.293% |
| Ainos, Inc. | -253.73 Thousand USD | -21050.58% |
| Pluri Inc. | 322 Thousand USD | 16766.46% |
| Prothena Corporation plc | -129.2 Million USD | 58.463% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | 206.43% |
| Celularity Inc. | 6.75 Million USD | 894.463% |
| Rallybio Corporation | -150 Thousand USD | -35677.333% |
| Cue Biopharma, Inc. | -32.6 Million USD | -64.584% |
| MeiraGTx Holdings plc | 287 Thousand USD | 18798.955% |
| Omeros Corporation | -69.77 Million USD | 23.091% |
| Humacyte, Inc. | -76.55 Million USD | 29.894% |
| Immunocore Holdings plc | 248.39 Million USD | 121.605% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | -253.787% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 186.028% |
| Blueprint Medicines Corporation | 236.58 Million USD | 122.684% |
| CalciMedica, Inc. | -58 Thousand USD | -92427.586% |
| Cabaletta Bio, Inc. | -1.42 Million USD | -3663.394% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | 284.705% |
| Scholar Rock Holding Corporation | -2.84 Million USD | -1786.99% |
| Sana Biotechnology, Inc. | -30.86 Million USD | -73.873% |
| Pulmatrix, Inc. | -8.22 Million USD | -552.871% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | -4486.838% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | -13350.125% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 86.543% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | 2033.502% |
| Cytokinetics, Incorporated | -322.59 Million USD | 83.364% |
| Eloxx Pharmaceuticals, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 6324.996% |
| Protara Therapeutics, Inc. | -341 Thousand USD | -15637.83% |
| Vor Biopharma Inc. | -3.49 Million USD | -1436.827% |
| Roivant Sciences Ltd. | 109.23 Million USD | 149.129% |
| Evogene Ltd. | 1.39 Million USD | 3936.026% |
| ProKidney Corp. | -3.16 Million USD | -1593.468% |
| Applied Therapeutics, Inc. | -43.91 Million USD | -22.213% |
| Hoth Therapeutics, Inc. | - USD | Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | 882.645% |
| CorMedix Inc. | -205.56 Thousand USD | -26006.965% |
| BioLineRx Ltd. | 1.1 Million USD | 4943.502% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 31.784% |
| Galectin Therapeutics Inc. | -33 Thousand USD | -162524.242% |
| Atai Life Sciences N.V. | -5000.00 USD | -1073220.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | -43939.423% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | -55802.083% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | -3763.643% |
| Sagimet Biosciences Inc. | 2 Million USD | 2783.3% |
| MediciNova, Inc. | 979.7 Thousand USD | 5577.771% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 36.354% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -56656.385% |
| GeoVax Labs, Inc. | -20.72 Million USD | -158.996% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 121.946% |
| Biomea Fusion, Inc. | -4.2 Million USD | -1177.458% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 106.152% |
| Mereo BioPharma Group plc | 7.42 Million USD | 822.677% |
| Cullinan Oncology, Inc. | -310 Thousand USD | -17211.613% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | -447116.667% |
| Absci Corporation | -41.84 Million USD | -28.237% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -1073220.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 29.732% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | -2080.658% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 125.109% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | -5603.082% |
| Allakos Inc. | -6.14 Million USD | -773.897% |
| Imunon, Inc. | -720 Thousand USD | -7353.559% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 22.219% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 111.277% |
| BioAtla, Inc. | -103.73 Million USD | 48.264% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -470324.264% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | -30049.438% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 77.899% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | -17155.949% |
| XOMA Corporation | 3.86 Million USD | 1489.951% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 23.427% |
| Cara Therapeutics, Inc. | 14.79 Million USD | 462.755% |
| aTyr Pharma, Inc. | -2.38 Million USD | -2147.32% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | 530.706% |
| Akero Therapeutics, Inc. | -29 Thousand USD | -184955.172% |
| Viridian Therapeutics, Inc. | -1 Million USD | -5224.008% |
| Eliem Therapeutics, Inc. | - USD | Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | 412815484.615% |
| Akari Therapeutics, Plc | -4000.00 USD | -1341550.0% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 108.426% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 27662.298% |
| UroGen Pharma Ltd. | 73.35 Million USD | 173.162% |
| Sutro Biopharma, Inc. | -26.69 Million USD | -101.041% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | 462339.449% |
| Orgenesis Inc. | -5.72 Million USD | -837.397% |
| Entera Bio Ltd. | -56 Thousand USD | -95732.143% |
| GH Research PLC | -315 Thousand USD | -16936.825% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | -28294.709% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | -10122.095% |
| Xencor, Inc. | -85.26 Million USD | 37.056% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | -24185.785% |
| Replimune Group, Inc. | -2.65 Million USD | -1921.318% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | -5259.975% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 130.176% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 27662.298% |
| Portage Biotech Inc. | -54 Thousand USD | -99281.481% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -56656.385% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | -14135.013% |
| OncoCyte Corporation | 413 Thousand USD | 13094.189% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | -1193804.338% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | -24173773.874% |
| Purple Biotech Ltd. | -196 Thousand USD | -27280.612% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | 698.417% |
| scPharmaceuticals Inc. | 9.78 Million USD | 648.62% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | -413.798% |
| HilleVax, Inc. | -2.15 Million USD | -2389.147% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | -55225.773% |
| Tharimmune, Inc. | - USD | Infinity% |
| Genprex, Inc. | -15 Thousand USD | -357577.953% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | -7933.832% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | -233230.435% |
| XTL Biopharmaceuticals Ltd. | - USD | Infinity% |
| Virios Therapeutics, Inc. | - USD | Infinity% |
| OKYO Pharma Limited | -7506.16 USD | -714859.447% |
| Savara Inc. | -44.26 Million USD | -21.246% |
| Curis, Inc. | 9.81 Million USD | 646.998% |
| Daré Bioscience, Inc. | 2.76 Million USD | 2037.735% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | -42905.738% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | -3003.875% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | -23437.719% |
| BeiGene, Ltd. | 2.07 Billion USD | 102.582% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | -1819.453% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 86.572% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 194.669% |
| Erasca, Inc. | -3.73 Million USD | -1337.996% |
| bluebird bio, Inc. | -4.03 Million USD | -1231.663% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -190083.571% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 102.818% |
| DBV Technologies S.A. | 15.72 Million USD | 441.213% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -190083.571% |
| Moderna, Inc. | 2.15 Billion USD | 102.49% |
| Vincerx Pharma, Inc. | -915 Thousand USD | -5765.137% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | 770.322% |
| Molecular Templates, Inc. | 50.39 Million USD | 206.491% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | -9912.313% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 140.113% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | -762.52% |
| Spruce Biosciences, Inc. | -39.34 Million USD | -36.405% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 51.708% |
| Cogent Biosciences, Inc. | -3.58 Million USD | -1395.708% |
| MacroGenics, Inc. | 50.52 Million USD | 206.213% |
| RenovoRx, Inc. | - USD | Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | -780.059% |
| Prime Medicine, Inc. | -147.9 Million USD | 63.716% |
| Aditxt, Inc. | -111.66 Thousand USD | -47961.974% |
| Adagene Inc. | 18.11 Million USD | 396.309% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | 11097.131% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 138.278% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 134.001% |
| SciSparc Ltd. | 2.19 Million USD | 2543.807% |
| Vericel Corporation | 135.57 Million USD | 139.584% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -214144.082% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | -173116.706% |
| Generation Bio Co. | -73.91 Million USD | 27.391% |
| Astria Therapeutics, Inc. | - USD | Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | -12180.549% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 198.255% |
| Invivyd, Inc. | -2.02 Million USD | -2546.252% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 82.161% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | -51782.287% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 155.689% |
| Artelo Biosciences, Inc. | - USD | Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 154.601% |
| ADMA Biologics, Inc. | 88.21 Million USD | 160.833% |
| Clene Inc. | 533 Thousand USD | 10168.668% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | 322.596% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | -5507.732% |
| GeoVax Labs, Inc. | -20.72 Million USD | -158.996% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | 2799.497% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | -27517.901% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | 207.752% |
| Relmada Therapeutics, Inc. | - USD | Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | -656.712% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | -6319.378% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 164.336% |
| Evaxion Biotech A/S | 73.11 Thousand USD | 73502.451% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 200.948% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 69.013% |
| Trevena, Inc. | 1.45 Million USD | 3788.385% |
| Surrozen, Inc. | -27.23 Million USD | -97.084% |
| Tyra Biosciences, Inc. | -353 Thousand USD | -15102.833% |
| Cingulate Inc. | -582.91 Thousand USD | -9106.441% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | -173016.129% |
| Unity Biotechnology, Inc. | -19.69 Million USD | -172.43% |
| Tenax Therapeutics, Inc. | -7570.00 USD | -708829.987% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | -5991.487% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 107.884% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | -5331.781% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | -95150.435% |
| Kronos Bio, Inc. | 1.37 Million USD | 4011.516% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | -18278.767% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | -10890.06% |
| ImmunityBio, Inc. | -17.89 Million USD | -199.978% |
| Korro Bio, Inc. | -3.63 Million USD | -1378.402% |
| Kineta, Inc. | 5.43 Million USD | 1087.778% |
| BioVie Inc. | -229.37 Thousand USD | -23296.417% |
| Codexis, Inc. | 57.33 Million USD | 193.602% |
| Celularity Inc. | 6.75 Million USD | 894.463% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | 1437.304% |
| Celcuity Inc. | -142.77 Thousand USD | -37488.603% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | 106180.253% |
| Cibus, Inc. | 1.42 Million USD | 3873.98% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | -14249.198% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | -134.155% |
| IN8bio, Inc. | -2.5 Million USD | -2045.782% |
| Kodiak Sciences Inc. | -25.94 Million USD | -106.829% |
| Annexon, Inc. | -3.26 Million USD | -1542.669% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | -2525.538% |
| Assembly Biosciences, Inc. | -41.73 Million USD | -28.581% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | 8485.313% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 106.893% |
| Eyenovia, Inc. | - USD | Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 131.029% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | -2724.526% |
| Arcellx, Inc. | 108.27 Million USD | 149.563% |
| Cardiff Oncology, Inc. | -32.36 Million USD | -65.794% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 167.757% |
| Regulus Therapeutics Inc. | -21.15 Million USD | -153.716% |
| Moolec Science SA | -143.3 Thousand USD | -37348.798% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | -26.816% |
| Geron Corporation | -123.5 Million USD | 56.547% |
| LAVA Therapeutics N.V. | 3.28 Million USD | 1732.674% |
| Royalty Pharma plc | 1.79 Billion USD | 102.992% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 23.433% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | -1485669.657% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | 23292.778% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 51.832% |
| Humacyte, Inc. | -76.55 Million USD | 29.894% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | -5553.969% |
| 89bio, Inc. | -273 Thousand USD | -19557.875% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | -4169.372% |
| Avenue Therapeutics, Inc. | - USD | Infinity% |
| Genelux Corporation | -848 Thousand USD | -6228.538% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | -43530.894% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | 4895.889% |
| Notable Labs, Ltd. | 113 Thousand USD | 47592.035% |
| Liquidia Corporation | 14.6 Million USD | 467.575% |
| Mustang Bio, Inc. | -2.22 Million USD | -2311.955% |
| Immunovant, Inc. | -231 Thousand USD | -23132.035% |
| Quantum-Si incorporated | 488 Thousand USD | 11097.131% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 3.407% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | -178786.667% |
| Vera Therapeutics, Inc. | 1.86 Million USD | 2982.17% |
| Acasti Pharma Inc. | -11 Thousand USD | -487772.727% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | -26127.537% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -8175.992% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 67.963% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | 4830.032% |
| NeuroBo Pharmaceuticals, Inc. | - USD | Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | -13985.564% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | -2640.858% |
| PepGen Inc. | -1.18 Million USD | -4432.601% |
| Moleculin Biotech, Inc. | -127 Thousand USD | -42156.693% |
| United Therapeutics Corporation | 2.07 Billion USD | 102.593% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -134.38% |
| Solid Biosciences Inc. | -76.56 Million USD | 29.906% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | -64884.319% |
| Immuneering Corporation | -764.13 Thousand USD | -6923.077% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | 81088.169% |
| Belite Bio, Inc | -399 Thousand USD | -13350.125% |
| XOMA Corporation | 3.86 Million USD | 1489.951% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | -167.848% |
| Bionomics Limited | -434.44 Thousand USD | -12252.658% |
| Apogee Therapeutics, Inc. | - USD | Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -4896.834% |
| uniQure N.V. | 2.21 Million USD | 2522.844% |
| Cassava Sciences, Inc. | -89.42 Million USD | 39.986% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 41.711% |
| Forte Biosciences, Inc. | -9000.00 USD | -596188.889% |
| Anebulo Pharmaceuticals, Inc. | - USD | Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | -6327.066% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | -12180.549% |
| Altimmune, Inc. | -65.37 Million USD | 17.908% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 114.824% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -4896.834% |
| Compugen Ltd. | 31.45 Million USD | 270.612% |
| Peak Bio, Inc. | 367.76 Thousand USD | 14692.312% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | 318.902% |
| Benitec Biopharma Inc. | 108 Thousand USD | 49790.741% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | -68702.564% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | -4361.014% |
| Zura Bio Limited | - USD | Infinity% |
| PolyPid Ltd. | -1.82 Million USD | -2845.445% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | -44997.479% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | -4361.014% |
| Instil Bio, Inc. | -4.75 Million USD | -1028.385% |
| argenx SE | 1.1 Billion USD | 104.841% |
| Immunome, Inc. | -8.9 Million USD | -502.515% |
| Compass Therapeutics, Inc. | -1.89 Million USD | -2739.471% |
| Verona Pharma plc | -679.62 Thousand USD | -7796.425% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | -30566.286% |
| Shattuck Labs, Inc. | -2.38 Million USD | -2150.147% |
| CervoMed Inc. | -1.29 Million USD | -4048.491% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | -2129.58% |
| Plus Therapeutics, Inc. | -4.77 Million USD | -1023.425% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | 2271.833% |
| Moolec Science SA | -143.3 Thousand USD | -37348.798% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | -13052.464% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | -1908.813% |
| AnaptysBio, Inc. | 14.78 Million USD | 463.074% |
| Design Therapeutics, Inc. | -537 Thousand USD | -9893.669% |
| Leap Therapeutics, Inc. | -427 Thousand USD | -12468.15% |
| NeurAxis, Inc. | 2.15 Million USD | 2588.334% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | 2600.746% |
| Lumos Pharma, Inc. | 2 Million USD | 2773.941% |
| Achilles Therapeutics plc | -4.73 Million USD | -1034.284% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | -30566.286% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | -50684.008% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | 269.514% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 6324.996% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | -5100.194% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | -17.823% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | 124904.651% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | -6428.71% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | -407758.337% |
| Palisade Bio, Inc. | 246 Thousand USD | 21915.447% |
| Tourmaline Bio, Inc. | -33 Thousand USD | -162524.242% |
| Beam Therapeutics Inc. | -59.67 Million USD | 10.065% |
| Neurogene Inc. | -3.26 Million USD | -1545.187% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 138.516% |
| AEON Biopharma, Inc. | - USD | Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | -1353.575% |
| Sesen Bio, Inc. | 40 Million USD | 234.165% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | -17969.36% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | -1232.642% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | -461.008% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | 481.151% |
| Athira Pharma, Inc. | -969 Thousand USD | -5438.287% |
| Vaccinex, Inc. | -16 Million USD | -235.329% |
| HCW Biologics Inc. | -574.82 Thousand USD | -9236.075% |
| XOMA Corporation | 3.86 Million USD | 1489.951% |
| Nektar Therapeutics | 53.47 Million USD | 200.352% |
| Arvinas, Inc. | 71.8 Million USD | 174.744% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Merus N.V. | -83.46 Million USD | 35.699% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 14.511% |
| Quince Therapeutics, Inc. | -322 Thousand USD | -16566.46% |
| Rezolute, Inc. | -36 Thousand USD | -148972.222% |
| Clene Inc. | 533 Thousand USD | 10168.668% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | -4179495.016% |
| BeyondSpring Inc. | 1.75 Million USD | 3164.877% |
| Synlogic, Inc. | -1.92 Million USD | -2689.293% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | -144943.243% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | -747.536% |
| Peak Bio, Inc. | 367.76 Thousand USD | 14692.312% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | -183.004% |
| Krystal Biotech, Inc. | 47.6 Million USD | 212.732% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 138.036% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | 1167.98% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | -1972.671% |
| MannKind Corporation | 136.19 Million USD | 139.405% |
| Ikena Oncology, Inc. | -50.49 Million USD | -6.286% |
| Cyclerion Therapeutics, Inc. | - USD | Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 149.319% |
| Gossamer Bio, Inc. | -4.38 Million USD | -1123.854% |
| CohBar, Inc. | - USD | Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | -21196.032% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -1073220.0% |
| Legend Biotech Corporation | 140.92 Million USD | 138.08% |
| Mural Oncology plc | -2.56 Million USD | -1990.612% |
| Biora Therapeutics, Inc. | -551 Thousand USD | -9639.746% |
| PaxMedica, Inc. Common Stock | - USD | Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | -53566.0% |
| Champions Oncology, Inc. | 20.75 Million USD | 358.581% |
| REGENXBIO Inc. | 53.02 Million USD | 201.201% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | -901.801% |
| Anavex Life Sciences Corp. | - USD | Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | -27796.556% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | -2998.499% |
| Vaxart, Inc. | -60.76 Million USD | 11.68% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | -20322.407% |
| Cellectis S.A. | 18 Thousand USD | 298244.444% |
| Longeveron Inc. | 221 Thousand USD | 24383.258% |
| Repare Therapeutics Inc. | -80.07 Million USD | 32.976% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 104.91% |
| Inozyme Pharma, Inc. | -1.29 Million USD | -4047.295% |
| Revolution Medicines, Inc. | -399.66 Million USD | 86.572% |
| Nymox Pharmaceutical Corporation | - USD | Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | -153231.429% |
| ArriVent BioPharma, Inc. Common Stock | - USD | Infinity% |
| AN2 Therapeutics, Inc. | - USD | Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | 109622.449% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 100.624% |
| Denali Therapeutics Inc. | -93.34 Million USD | 42.508% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -214144.082% |
| Veru Inc. | 7.56 Million USD | 809.312% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | -35440.397% |
| Cingulate Inc. | -582.91 Thousand USD | -9106.441% |
| Passage Bio, Inc. | -3.72 Million USD | -1342.247% |
| Context Therapeutics Inc. | -12.04 Thousand USD | -445482.863% |
| Exicure, Inc. | -1.42 Million USD | -3671.328% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | -13912.01% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | 2085.424% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | -10367.84% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 178.775% |
| Nuvalent, Inc. | - USD | Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | -35771.316% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 9.357% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | 13825.32% |
| OmniAb, Inc. | 14.66 Million USD | 465.896% |
| Anew Medical, Inc. | - USD | Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | 368.424% |
| Lipocine Inc. | -2.85 Million USD | -1782.477% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | -2811.883% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | -840.684% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -3462.791% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 171.254% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | -82463.077% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 163.664% |
| Ocugen, Inc. | -33.53 Million USD | -60.02% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | -1597.217% |
| Q32 Bio Inc. | 578 Thousand USD | 9384.775% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | -20151.321% |
| Alumis Inc. Common Stock | -1.28 Million USD | -4079.595% |
| Equillium, Inc. | 35.95 Million USD | 249.246% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | -3043.878% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | 10818.644% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | -1298061.587% |
| Galera Therapeutics, Inc. | -259 Thousand USD | -20620.463% |
| Evelo Biosciences, Inc. | - USD | Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | 12795.641% |
| Dominari Holdings Inc. | 2.03 Million USD | 2731.976% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | -29150.399% |
| vTv Therapeutics Inc. | -13.59 Million USD | -294.748% |
| Bio-Techne Corporation | 773.07 Million USD | 106.942% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | 409.868% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 111.647% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | -4490.761% |
| Candel Therapeutics, Inc. | -23.98 Million USD | -123.795% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | 558.801% |
| Nkarta, Inc. | -5.86 Million USD | -814.398% |
| BioCardia, Inc. | -7.24 Million USD | -640.323% |
| Iterum Therapeutics plc | -1.75 Million USD | -2966.629% |